BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 32005765)

  • 1. Mitochondrial Dysfunction Combined with High Calcium Load Leads to Impaired Antioxidant Defense Underlying the Selective Loss of Nigral Dopaminergic Neurons.
    Ricke KM; Paß T; Kimoloi S; Fährmann K; Jüngst C; Schauss A; Baris OR; Aradjanski M; Trifunovic A; Eriksson Faelker TM; Bergami M; Wiesner RJ
    J Neurosci; 2020 Feb; 40(9):1975-1986. PubMed ID: 32005765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of the Sodium Leak Channel NALCN to Pacemaking of Medial Ventral Tegmental Area and Substantia Nigra Dopaminergic Neurons.
    Cobb-Lewis DE; Sansalone L; Khaliq ZM
    J Neurosci; 2023 Oct; 43(41):6841-6853. PubMed ID: 37640554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic methamphetamine-induced neurodegeneration: Differential vulnerability of ventral tegmental area and substantia nigra pars compacta dopamine neurons.
    Du Y; Lee YB; Graves SM
    Neuropharmacology; 2021 Dec; 200():108817. PubMed ID: 34610287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential contribution of Ih to the integration of excitatory synaptic inputs in substantia nigra pars compacta and ventral tegmental area dopaminergic neurons.
    Masi A; Narducci R; Resta F; Carbone C; Kobayashi K; Mannaioni G
    Eur J Neurosci; 2015 Nov; 42(9):2699-706. PubMed ID: 26354486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sirt3 protects dopaminergic neurons from mitochondrial oxidative stress.
    Shi H; Deng HX; Gius D; Schumacker PT; Surmeier DJ; Ma YC
    Hum Mol Genet; 2017 May; 26(10):1915-1926. PubMed ID: 28369333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial oxidant stress mediates methamphetamine neurotoxicity in substantia nigra dopaminergic neurons.
    Graves SM; Schwarzschild SE; Tai RA; Chen Y; Surmeier DJ
    Neurobiol Dis; 2021 Aug; 156():105409. PubMed ID: 34082123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine Inhibition Differentially Controls Excitability of Substantia Nigra Dopamine Neuron Subpopulations through T-Type Calcium Channels.
    Evans RC; Zhu M; Khaliq ZM
    J Neurosci; 2017 Mar; 37(13):3704-3720. PubMed ID: 28264982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low Levels of Prohibitin in Substantia Nigra Makes Dopaminergic Neurons Vulnerable in Parkinson's Disease.
    Dutta D; Ali N; Banerjee E; Singh R; Naskar A; Paidi RK; Mohanakumar KP
    Mol Neurobiol; 2018 Jan; 55(1):804-821. PubMed ID: 28062948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A WNT1-regulated developmental gene cascade prevents dopaminergic neurodegeneration in adult En1(+/-) mice.
    Zhang J; Götz S; Vogt Weisenhorn DM; Simeone A; Wurst W; Prakash N
    Neurobiol Dis; 2015 Oct; 82():32-45. PubMed ID: 26049140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sox6 expression distinguishes dorsally and ventrally biased dopamine neurons in the substantia nigra with distinctive properties and embryonic origins.
    Pereira Luppi M; Azcorra M; Caronia-Brown G; Poulin JF; Gaertner Z; Gatica S; Moreno-Ramos OA; Nouri N; Dubois M; Ma YC; Ramakrishnan C; Fenno L; Kim YS; Deisseroth K; Cicchetti F; Dombeck DA; Awatramani R
    Cell Rep; 2021 Nov; 37(6):109975. PubMed ID: 34758317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMDA alters rotenone toxicity in rat substantia nigra zona compacta and ventral tegmental area dopamine neurons.
    Munhall AC; Wu YN; Belknap JK; Meshul CK; Johnson SW
    Neurotoxicology; 2012 Jun; 33(3):429-35. PubMed ID: 22521663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson's disease.
    Benkert J; Hess S; Roy S; Beccano-Kelly D; Wiederspohn N; Duda J; Simons C; Patil K; Gaifullina A; Mannal N; Dragicevic E; Spaich D; Müller S; Nemeth J; Hollmann H; Deuter N; Mousba Y; Kubisch C; Poetschke C; Striessnig J; Pongs O; Schneider T; Wade-Martins R; Patel S; Parlato R; Frank T; Kloppenburg P; Liss B
    Nat Commun; 2019 Nov; 10(1):5094. PubMed ID: 31704946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Somatic Ca2+ Channel Profile in Midbrain Dopaminergic Neurons.
    Philippart F; Destreel G; Merino-Sepúlveda P; Henny P; Engel D; Seutin V
    J Neurosci; 2016 Jul; 36(27):7234-45. PubMed ID: 27383597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Impact of Mitochondrial Dysfunction on Dopaminergic Neurons in the Olfactory Bulb and Odor Detection.
    Paß T; Aßfalg M; Tolve M; Blaess S; Rothermel M; Wiesner RJ; Ricke KM
    Mol Neurobiol; 2020 Sep; 57(9):3646-3657. PubMed ID: 32564285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-OHDA induced calcium influx through N-type calcium channel alters membrane properties via PKA pathway in substantia nigra pars compacta dopaminergic neurons.
    Qu L; Wang Y; Zhang HT; Li N; Wang Q; Yang Q; Gao GD; Wang XL
    Neurosci Lett; 2014 Jul; 575():1-6. PubMed ID: 24861516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.
    Surmeier DJ; Guzman JN; Sanchez-Padilla J; Schumacker PT
    Neuroscience; 2011 Dec; 198():221-31. PubMed ID: 21884755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Synuclein-Dependent Calcium Entry Underlies Differential Sensitivity of Cultured SN and VTA Dopaminergic Neurons to a Parkinsonian Neurotoxin.
    Lieberman OJ; Choi SJ; Kanter E; Saverchenko A; Frier MD; Fiore GM; Wu M; Kondapalli J; Zampese E; Surmeier DJ; Sulzer D; Mosharov EV
    eNeuro; 2017; 4(6):. PubMed ID: 29177188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe nigrostriatal degeneration without clinical parkinsonism in patients with polymerase gamma mutations.
    Tzoulis C; Tran GT; Schwarzlmüller T; Specht K; Haugarvoll K; Balafkan N; Lilleng PK; Miletic H; Biermann M; Bindoff LA
    Brain; 2013 Aug; 136(Pt 8):2393-404. PubMed ID: 23625061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of interleukin-13 receptor α1 delays the loss of dopaminergic neurons during chronic stress.
    Mori S; Sugama S; Nguyen W; Michel T; Sanna MG; Sanchez-Alavez M; Cintron-Colon R; Moroncini G; Kakinuma Y; Maher P; Conti B
    J Neuroinflammation; 2017 Apr; 14(1):88. PubMed ID: 28427412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.